Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2020
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient PopulationsVeronica Ashton, Lana Mudarris, Kenneth T MooreJournal of Clinical Pharmacology|February 18, 2021
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient PopulationsVeronica Ashton, Sylvia Kerolus-Georgi, Kenneth T MooreJournal of Clinical Pharmacology|September 1, 2011
Randomized 5-treatment crossover study to assess the effects of external heat on serum fentanyl concentrations during treatment with transdermal fentanyl systemsKenneth T Moore, Gayatri Sathyan, Ute Richarz, et al.Current Medical Research and Opinion|June 23, 2018
Influence of age on the pharmacokinetics, pharmacodynamics, efficacy, and safety of rivaroxabanKenneth T Moore, Peggy Wong, Liping Zhang, et al.Journal of Clinical Pharmacology|June 26, 2014
An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal functionKenneth T Moore, Seema Vaidyanathan, Jaya Natarajan, et al.Journal of Clinical Pharmacology|November 9, 2023
The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug DevelopmentKenneth T Moore, Peter N Zannikos, Joanna C Masters, et al.Journal of Aircraft|June 2, 2020
Monolithic Approach for Next-Generation Aircraft Design Considering Airline Operations and EconomicsSatadru Roy, William A Crossley, Kenneth T Moore, et al.American Heart Journal|March 1, 2020
Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney diseaseMatthew R Weir, Veronica Ashton, Kenneth T Moore, et al.Clinical Pharmacology in Drug Development|April 30, 2016
Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tubeKenneth T Moore, Mark A Krook, Seema Vaidyanathan, et al.Pageof 2